Patents Examined by Susan Hoffman
  • Anti-inflammatory botanical extract
    Patent number: 11311590
    Abstract: A botanical extract that exhibits anti-inflammatory activity, wherein the botanical extract is at least an extract from the genus Anacardium.
    Type: Grant
    Filed: January 27, 2021
    Date of Patent: April 26, 2022
    Assignee: Innophos, LLC
    Inventors: Jatinder Rana, Kylie Mitchell
  • Platelet lysate gel
    Patent number: 11304981
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: April 19, 2022
    Assignee: Cell Therapy Limited
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Pharmaceutical micronutrient composition for simultaneously treating nervous system function, cognitive ability and response to stressors
    Patent number: 11304922
    Abstract: A pharmaceutical composition of micronutrients were tried to improve cognitive brain function, brain health and nervous system functions. Combination consisting of Avena sativa (green oat straw extract), Coenzyme Q10, NAD+, American Ginseng, and Pyrroloquinoline quinone in physiological dose range shows multiple simultaneous positive effects in supporting key functions in cells building our nervous system essential for optimum mental and/or cognitive health including protecting nervous system cells against various damaging factors, increasing ATP production, stimulating mitochondria biogenesis, increasing mitochondrial membrane potential, increasing mitochondrial functions (Complex I activity), exhibiting anti-inflammatory capacity and increased BDNF secretion.
    Type: Grant
    Filed: December 15, 2021
    Date of Patent: April 19, 2022
    Inventor: Matthias W Rath
  • Pharmaceutical micronutrient composition and its use to simultaneously treat nervous system function, cognitive ability and response to stressors
    Patent number: 11304921
    Abstract: A pharmaceutical composition of micronutrients were tried to improve brain health and nervous system functions. Combination of L-theanine, Rhodiola rosea, Acetyl L-Carnitine (ALCAR), Bacopa monnieri, Mucuna pruriens, NAD+, Rose hips extract (trans-tiliroside), American Ginseng, Pyrroloquinoline quinone, Gotu Kola in physiological dose range shows multiple simultaneous positive effects in supporting key functions in cells building our nervous system essential for optimum mental and/or cognitive health including protecting nervous system cells against various damaging factors, increasing ATP production, stimulating mitochondria biogenesis, increasing mitochondrial membrane potential, increasing mitochondrial functions (Complex I activity), exhibiting anti-inflammatory capacity and increased BDNF secretion.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: April 19, 2022
    Inventor: Matthias W Rath
  • Compositions of whole green coffee bean products and whole hemp products
    Patent number: 11297848
    Abstract: Disclosed are novel processing methods for green coffee beans that result in novel green coffee bean products, including products that incorporate whole green coffee beans which is combined with a whole hemp powder or CBD. Methods for processing green coffee beans include selecting whole coffee beans in their fresh green unroasted state with naturally-occurring levels of phytonutrients, sterilizing and drying them, applying iterative grinding processes and stabilization techniques, all while avoiding high temperatures. A similar method is used to prepare a whole hemp powder, which may then be combined with the whole green coffee bean powder.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: April 12, 2022
    Inventor: Thomas Vella
  • Botanical modulator of metabolic disorders
    Patent number: 11297869
    Abstract: Plant-based inhibitors of MMP-9 that also function as PPAR-? agonists, and the use of such plant-based inhibitors/agonists in modulating metabolic disorders is disclosed. The plant-based inhibitor/agonist is at least an extract obtained from the genus Anacardium.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: April 12, 2022
    Assignee: Innophos, LLC
    Inventors: Jatinder Rana, Kylie Mitchell
  • Composition comprising extract for preventing or treating ischemia-reperfusion injury and use thereof
    Patent number: 11285186
    Abstract: Provided are a pharmaceutical composition including a Crepidiastrum denticulatum extract as an active ingredient; and a method for preventing or treating ischemia-reperfusion injury in a subject by using a food composition or the pharmaceutical composition.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: March 29, 2022
    Assignees: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Chu Won Nho, Hak Cheol Kwon, Ji-Hye Yoo, Jaeyoung Kwon, Jin Soo Park, Hyuk-Jai Jang, Seong-Su Kim, Cheon Soo Park, Hwa-Mi Lee, Hee Ju Lee
  • Pharmaceutical composition for preventing and treating senile dementia and preparation method thereof
    Patent number: 11278584
    Abstract: The present disclosure relates to a pharmaceutical composition for preventing and treating senile dementia and preparation method thereof. The active ingredients of the pharmaceutical composition are prepared from raw medicinal materials comprising 20-50 parts by weight of Epimedii Folium and 15-55 parts by weight of Poria; or from raw medicinal materials comprising 20-50 parts by weight of Epimedii Folium, 15-55 parts by weight of Poria and 10-55 parts by weight of Acanthopanax, or from raw medicinal materials comprising 20-50 parts by weight of Epimedii Folium, 15-50 parts by weight of Poria, 15-50 parts by weight of Acanthopanax and 6-15 parts by weight of Anemarrhenae Rhizoma.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: March 22, 2022
    Assignee: SICHUAN JISHENGTANG PHARMACEUTICAL CC
    Inventors: Xiao Ke, Xiaofeng Hao, Baohua Meng
  • Method of extracting follicular fluid and application thereof in treatment of various medical conditions
    Patent number: 11278576
    Abstract: Disclosed is a method of extracting follicular fluid from a Graafian Follicle, from a human, female donor, and conversion thereof into different forms of medications. The invention also teaches various methods of administering said medications to patients, both male and female, aesthetic rejuvenations and/or suffering from a wide variety of medical conditions, including but not limited to systemic acute and chronic diseases.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: March 22, 2022
    Inventor: Nishit Pancholi
  • Traditional Chinese medicine composition for treating diseases caused by human papillomavirus, preparation method and use thereof
    Patent number: 11278583
    Abstract: The present invention discloses a traditional Chinese medicine composition for treating diseases caused by human papillomavirus, a preparation method and use thereof. The traditional Chinese medicine composition comprises: 15-60 parts of Rhizoma Smilacis Glabrae, 7.5-30 parts of Sophora Flavescens, 10-40 parts of Herba Hedyotidis Diffusae, 10-40 parts of Herba Taraxaci, 6-24 parts of Dysosma Versipellis, 7.5-30 parts of Nidus Vespae, 10-40 parts of Cortex Phellodendri, 2.5-10 parts of Fructus Bruceae, 7.5-30 parts of Fructus Cnidii, 3-12 parts of Radix Glycyrrhizae, 7.5-30 parts of Flos Lonicerae, 7.5-30 parts of Folium Isatidis, 5-20 parts of Radix Semiaquilegiae, and 1000-2000 parts of 75% ethanol. The traditional Chinese medicine composition has good curative effect and good safety.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: March 22, 2022
    Inventor: Zhuanshe Du
  • Pharmaceutical composition containing avocado oil fraction as active ingredient for prevention or treatment of hearing loss
    Patent number: 11273194
    Abstract: The present invention relates to a pharmaceutical composition containing an avocado oil fraction as an active ingredient for prevention or treatment of hearing loss. Specifically, the avocado oil fraction according to the present invention, especially, an isopropanol fraction of avocado oil significantly increases the number of hair cells reduced by neomycin in zebrafish models, so the isopropanol fraction of avocado oil can be favorably used in the treatment of hearing loss.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: March 15, 2022
    Assignee: DONG KOOK PHARM CO., LTD
    Inventors: Bin Na Hong, Woo Jae Jung, Kye Wan Lee, Jung Suk Lee, Yu Hwa Park, Do Hoon Kim
  • Dietary supplement for glycemia control and diabetes prevention
    Patent number: 11266668
    Abstract: A formulation for a dietary supplement includes standardized extracts of astragalus root, phlorizin, root bark of white mulberry, olive leaf, and bitter melon. The formulation may further include chromium, 2-deoxy-D-glucose, biotin, vitamin D and vitamin C. A method of controlling postprandial blood glucose includes administering the formulation for the dietary supplement to a patient.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: March 8, 2022
    Assignee: WORLD PHARMACEUTICAL TECHNOLOGY, LLC
    Inventors: Yong Wu, Wei Cao, Jieqing Li, Huabing Yang, Ke Wu, Shiliu Tian
  • Topical skin care formulations comprising plant extracts
    Patent number: 11266594
    Abstract: A method of treating a skin condition resulting from exposure to pollution or free radicals is disclosed. The method can include topically applying to skin having the skin condition a composition comprising an effective amount of an extract of Diospyros mespiliformis leaf to reduce oxidative damage in the skin having the skin condition.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: March 8, 2022
    Assignee: MARY KAY INC.
    Inventors: Tiffany Florence, Michelle Hines
  • Body butter and method of manufacture
    Patent number: 11266592
    Abstract: A body butter that includes a base oil, beeswax, shea butter, cocoa butter, and vitamin E oil.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: March 8, 2022
    Inventor: Diane Sica
  • Method for suppressing obesity or development of obesity
    Patent number: 11260098
    Abstract: An appetite-suppressing composition is characterized by comprising, as an active component, the liquid component derived from Indian mulberry (Morinda citrifolia). The solution is the liquid component extracted from fermented Indian mulberry fruits, which includes the residual liquid containing the >3,000 component and the filtrated liquid containing the <3,000 component. Considerably, provided is the food that possesses the appetite-suppressing composition without showing the non-specific effect on appetite suppression.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: March 1, 2022
    Inventor: Masatomo Mori
  • Method of maximizing epigallocatechin gallate content in tea
    Patent number: 11260045
    Abstract: This invention describes a new method to maximize the epigallocatechin gallate (EGCG) content of brewed tea made using leaves and buds from C. sinensis. Unlike conventional tea processing methods, the method of the invention aims to minimize the leaf withering step, the oxidation step and any heating steps, all of which are present in many conventional tea processing methods. The method of the invention treats minimally withered tea leaf and bud material with an acid treatment and then a maceration treatment, optionally freezing the acid-treated material for storage purposes. The brewed tea resulting from the acid-treated and macerated leaves has a significantly higher EGCG content than conventionally produced teas.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: March 1, 2022
    Assignee: MILLENNIA TEA INC.
    Inventor: Rory Bell
  • Composition for improving cognitive ability and preventing or treating dementia and attention deficit hyperactivity disorder, comprising galla rhois extract and fraxin as active ingredients
    Patent number: 11253553
    Abstract: The present invention relates to a composition for improving cognitive ability, and preventing or treating dementia and a hyperactivity disorder, which includes a Galla rhois extract and fraxin as active ingredients. It was identified that the composition including the Galla rhois extract and fraxin significantly improves cognitive memory in an Alzheimer's disease model induced by A? (1-42) administration and an APPswe/PS1dE9 double-expressing Alzheimer's disease model, and inhibits the generation of amyloid plaques, suggesting the usefulness of the combination of the Galla rhois extract and fraxin, as a therapeutic material, against Alzheimer's disease, and showing that the combination of the Galla rhois extract and fraxin is able to be used as a therapeutic agent for ADHD.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: February 22, 2022
    Inventors: Sang Hee Kim, Hyun Kee Kim
  • Urtica dioica extracts and methods of isolating urtica dioica extracts
    Patent number: 11246899
    Abstract: A method of isolating an extract of Urtica dioica is described herein. The method includes drying a raw material comprising Urtica dioica; grinding the raw material to form a ground raw material having a particle size in a range of about 0.5 to 1 mm; mixing the ground raw material with water to form a mixed raw material solution; and heating the mixed raw material solution to a temperature of about 100° C. and maintaining the temperature of about 100° C. for a period of time to form an extracted liquid solution.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: February 15, 2022
    Assignee: SynHiTech Inc.
    Inventors: Masoud Shabani, Mohammad Massumi
  • Composition for preventing or treating cancer
    Patent number: 11235018
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating cancer, a food composition for enhancing immune functions, and a pharmaceutical composition for preventing or treating cachexia. The composition of the present invention provides effects of further inhibiting the growth of tumors, increasing immunological activity, and suppressing cachexia caused by tumors. In addition, the composition of the present invention can obtain a synergistic effect when co-administered with an existing anticancer drug.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: February 1, 2022
    Assignee: OKCHUNDANG CO., LTD.
    Inventors: Sae Kwang Ku, Seong Min Ku, Tae Hun Ku, Chui Jong Jung, Gyung Yun Beik, Jin Gi Shin, Sang Soo Lee, Jeong Gyun Seo, Chil Surk Yoon, Xian Li
  • Pharmaceutical micronutrient composition and its use to simultaneously improve nervous system function, cognitive ability and response to stressors
    Patent number: 11234952
    Abstract: A pharmaceutical composition of micronutrients were tried to improve brain health and nervous system functions. Various combinations of formulas were used. Formulas 12, 10 and 5 shows multiple simultaneous positive effects in supporting key functions in cells building our nervous system essential for optimum mental health including protecting nervous system cells against various damaging factors, increasing ATP production, stimulating mitochondria biogenesis, increasing mitochondrial membrane potential, increasing mitochondrial functions (Complex I activity), exhibiting anti-inflammatory capacity and increased BDNF secretion.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: February 1, 2022
    Inventor: Matthias W Rath